Exosens falls as full-year results trigger profit-taking

Exosens SA

23/02/2026 11:54

** Shares in night-vision equipment maker Exosens EXENS.PA fall around 3% after posting its full-year results

** An analyst, who preferred staying anonymous, pointed to profit-taking after a strong run and continuing peace talks in Ukraine despite strong results

** "Nice beat at EBIT, guidance looks fine (...) although macro factors are likely to overwhelm," brokerage Citi says regarding the share performance

** Additionally, the broker notes the higher level of investment at around 9% of 2026 revenue is logical, but "may be regarded as a negative by the market"

** Exosens expects 2026 revenue of 520 million to 540 million euros and adjusted EBITDA of 168 million to 178 million euros, with growth slowing to around 13%-14% from 22% and 27% in 2025

** Up to previous session's close, EXENS shares up 26.9% YTD

($1 = 0.8471 euros)

(Reporting by Jakob Van Calster and Hugo Lhomedet)

((jakob.vancalster@thomsonreuters.com))